0001181431-13-032683.txt : 20130604
0001181431-13-032683.hdr.sgml : 20130604
20130604200245
ACCESSION NUMBER: 0001181431-13-032683
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130603
FILED AS OF DATE: 20130604
DATE AS OF CHANGE: 20130604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOEHR MATTHEW W
CENTRAL INDEX KEY: 0001237556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 13892919
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES RD #300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
rrd382315.xml
FORM 4 - MATT FOEHR 6-3-2013
X0306
4
2013-06-03
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001237556
FOEHR MATTHEW W
11119 NORTH TORREY PINES ROAD
SUITE 200
LA JOLLA
CA
92037
0
1
0
0
EVP and COO
Common Stock
2013-06-03
4
A
0
8333
0
A
43870
D
These shares are represented by restricted stock units, which will vest on April 18, 2014, subject to the Reporting Person's continued status as an employee, director or consultant to the Company or its subsidiaires on each such date.
By: John P. Sharp For: Matthew W. Foehr
2013-06-04